159 related articles for article (PubMed ID: 19108950)
21. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism.
Gómez Del Pulgar T; Valdés-Mora F; Bandrés E; Pérez-Palacios R; Espina C; Cejas P; García-Cabezas MA; Nistal M; Casado E; González-Barón M; García-Foncillas J; Lacal JC
Int J Oncol; 2008 Jul; 33(1):185-93. PubMed ID: 18575765
[TBL] [Abstract][Full Text] [Related]
22. p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors.
Wassermann S; Scheel SK; Hiendlmeyer E; Palmqvist R; Horst D; Hlubek F; Haynl A; Kriegl L; Reu S; Merkel S; Brabletz T; Kirchner T; Jung A
Gastroenterology; 2009 Jan; 136(1):196-205.e2. PubMed ID: 18951899
[TBL] [Abstract][Full Text] [Related]
23. MiR-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of SOX7 via the Wnt signaling pathway.
Bai QL; Hu CW; Wang XR; Shang JX; Yin GF
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5630-5637. PubMed ID: 29271996
[TBL] [Abstract][Full Text] [Related]
24. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
25. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases.
Bandapalli OR; Dihlmann S; Helwa R; Macher-Goeppinger S; Weitz J; Schirmacher P; Brand K
J Pathol; 2009 Jul; 218(3):370-9. PubMed ID: 19347947
[TBL] [Abstract][Full Text] [Related]
27. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
Zhao X; Li D; Zhao ST; Zhang Y; Xu A; Hu YY; Fang Z
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9304-9312. PubMed ID: 31773697
[TBL] [Abstract][Full Text] [Related]
29. SOX15 and SOX7 differentially regulate the myogenic program in P19 cells.
Savage J; Conley AJ; Blais A; Skerjanc IS
Stem Cells; 2009 Jun; 27(6):1231-43. PubMed ID: 19489079
[TBL] [Abstract][Full Text] [Related]
30. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.
Man CH; Fung TK; Wan H; Cher CY; Fan A; Ng N; Ho C; Wan TS; Tanaka T; So CW; Kwong YL; Leung AY
Blood; 2015 Jun; 125(25):3928-36. PubMed ID: 25940713
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
32. Wnt signaling inhibits cementoblast differentiation and promotes proliferation.
Nemoto E; Koshikawa Y; Kanaya S; Tsuchiya M; Tamura M; Somerman MJ; Shimauchi H
Bone; 2009 May; 44(5):805-12. PubMed ID: 19442631
[TBL] [Abstract][Full Text] [Related]
33. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
34. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
35. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
[TBL] [Abstract][Full Text] [Related]
36. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway.
Liu H; Yan ZQ; Li B; Yin SY; Sun Q; Kou JJ; Ye D; Ferns K; Liu HY; Liu SL
J Ovarian Res; 2014 Sep; 7():87. PubMed ID: 25297608
[TBL] [Abstract][Full Text] [Related]
37. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
[TBL] [Abstract][Full Text] [Related]
38. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
39. SOX17 directly activates Zfp202 transcription during in vitro endoderm differentiation.
Patterson ES; Addis RC; Shamblott MJ; Gearhart JD
Physiol Genomics; 2008 Aug; 34(3):277-84. PubMed ID: 18523156
[TBL] [Abstract][Full Text] [Related]
40. Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer.
Peng W; Guo L; Tang R; Liu X; Jin R; Dong JT; Xing CG; Zhou W
Prostate; 2019 Mar; 79(4):370-378. PubMed ID: 30488457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
